Robert Keith Warner - 06 Jun 2024 Form 4 Insider Report for RxSight, Inc. (RXST)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Jun 2024, 16:25:46 UTC
Prior SEC filing
31 May 2024
Next SEC filing
19 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shelley Thunen, as Attorney-in-Fact

Key filing fact

Robert Keith Warner filed Form 4 for RxSight, Inc. (RXST) on 10 Jun 2024.

Key facts

  • This page summarizes Robert Keith Warner's Form 4 filing for RxSight, Inc. (RXST).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Jun 2024, 16:25.

Change

  • Previous filing in this sequence was filed on 31 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RXST transaction

Common Stock

Award

Transaction value
Shares
+2,554
Change %
+9.2%
Price
Shares after
30,287
Date
06 Jun 2024
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.

Footnote F2

Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the date immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 6, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .